Abstract:With the aim of assessing whether transition metal complexes might be utilized as efficient biocatalysts and biological drugs, new monofunctional nickel(II) and copper(II) complexes of types NiL (1) and CuL (2) [H2L = N-(N',N'-diethylaminothiocarbonyl)benzimidoyl chloride-2-aminoacetophenone-N-methylthiosemicarbazone] were synthesized. The compounds are remarkably stable and were obtained in good yields. Structural elucidation was carried out thoroughly in solid and solution-states by elemental analysis and various spectroscopy techniques (IR, UV-vis, H-1 NMR, and EPR) as well as ESI mass spectrometry. The molecular structure of the compounds was investigated by single-crystal X-ray diffraction. The analyses showed tetradentate coordination of the ligand in nickel(II) and copper(II) complexes, in which the metal atom exhibits a square planar geometry with N2S2 in a donor fashion. Structural optimization, HOMO-LUMO energy calculations and Natural Bond Orbital (NBO) analysis of H2L and its complexes (1 and 2) were investigated by Density Functional Theory (DFT). The trend in binding affinities of the compounds with biomolecules, such as calf thymus DNA (CT-DNA) and bovine serum albumin (BSA) protein, were investigated by different spectrophotometric methods, which revealed an intercalative mode of interaction. Furthermore, enzyme kinetic studies reflected that the square planar complexes (1 and 2) are also effective in mimicking catecholase (3,5-DTBC) and phosphatase (4-NPP) activities over the parent H2L. The high k(cat) values suggested that the selected compounds displayed a high rate of catalytic efficiency. In vitro cytotoxicity of the complexes on human skin cancer melanoma (A375), human cervical cancer (HeLa) and human hepatocellular carcinoma (Hep3B) cancer cell lines demonstrated that the complexes had a broad-spectrum of anti-cancer activity with low IC50 values. The morphological assessment data obtained by acridine orange/ethidium bromide (AO/EB) and diamidino-2-phenylindole (DAPI) staining revealed that complex 2 induces apoptosis much more effectively than 1.

Synthesis And Structure Of New Dicopper(Ii) Complexes Bridged By Asymmetric N, N '-Bis( Substituted) Oxamides: In Vitro Anticancer Activity And Molecular Docking Studies Based On Bio-Macromolecular Interaction

Synthesis, Characterization, DNA/HSA Interactions, and Anticancer Activity of Two Novel Copper(II) Complexes with 4-Chloro-3-Nitrobenzoic Acid Ligand

Crystal Structures, Interactions with Biomacromolecules and Anticancer Activities of Mn(II), Ni(II), Cu(II) Complexes of Demethylcantharate and 2-Aminopyridine

1‐Benzyl‐1H‐indazol‐3‐ol Copper(II) Derivatives as Anticancer Agents: In‐vitro Interaction with DNA/BSA, DFT, Molecular Docking and Cytotoxicity on MCF7 Cells

Synthesis, structural studies, interaction with DNA/HSA and antitumor evaluation of new Cu(II) complexes containing 2-(1H-imidazol-2-yl)pyridine and amino acids

Crystal structure, in vitro cytotoxicity, DNA binding and DFT calculations of new copper (II) complexes with coumarin-amide ligand

Synthesis, characterization and biological activity of novel copper complexes containing a β-carboline derivative and amino acids

Synthesis, Crystal Structure, Dna Binding, Antibacterial, and Cytotoxic Activities of Two Chiral Copper(Ii) Complexes

Synthesis, Characterization, Dna/Bsa Interactions and Anticancer Activity of Achiral and Chiral Copper Complexes

Copper(II) complexes incorporated with 2,2-bipyridyl and 2,2′-(((1E,1′E)-1,4-phenylene-bis(methanylylidene))bis(azanylylidene)) diphenol derivatives: In-vitro interaction with DNA/BSA, DFT, molecular docking and cytotoxicity

Synthesis, Crystal Structure, DNA-binding Properties, Cytotoxic and Antioxidation Activities of Several Ternary Copper(ii) Complexes with a New Reduced Schiff Base Ligand

Two Novel Copper Complexes of 2,2′-Bipyridine: Evaluation of the DNA Binding and Cytotoxic Activity

Synthesis, structure, and biological properties of Cu(II) complexes based on diimine ligands

Synthesis, structure and anticancer studies of Cu (II), Ni (II) and Co (II) complexes based on 2,3-dihydroxybenzaldehyde-2-(2-aminophenyl)benzimidazole Schiff base

A series of DNA targeted Cu (II) complexes containing 1,8-naphthalimide ligands: Synthesis, characterization and in vitro anticancer activity

Two Water-Soluble Copper(ii) Complexes: Synthesis, Characterization, DNA Cleavage, Protein Binding Activities and in Vitro Anticancer Activity Studies.

The X-ray crystal structures, molecular docking and biological activities of two novel Cu(II) and Zn(II) complexes with a ligand having a potentially N4O2 donor set and two nitro phenyl rings as pendant arms

Interaction with DNA and Different Effect on the Nucleus of Cancer Cells for Copper(ii) Complexes of N-benzyl Di(pyridylmethyl)amine

Antitumor copper(II) complexes with hydroxyanthraquinones and N,N-heterocyclic ligands

Nickel(Ii) And Copper(Ii) Complexes Constructed With N2s2 Hybrid Benzamidine-Thiosemicarbazone Ligand: Synthesis, X-Ray Crystal Structure, Dft, Kinetico-Catalytic And In Vitro Biological Applications

Five Novel Dinuclear Copper(ii) Complexes: Crystal Structures, Properties, Hirshfeld Surface Analysis and Vitro Antitumor Activity Study